Power-Trition introduces Trimfizz diet drink mix
DAYTON, N.J. Power-Trition on Wednesday introduced Trimfizz, an effervescent stick pack diet aid.
Because the citrus-flavored diet aid is dissolved in water, its ingredients are absorbed four times more quickly than weight-loss tablets, the company claimed. The recommended daily dosage of one stick pack dissolved in a full 8 oz. glass of water consumed 20 minutes before each meal also helps contribute to necessary water intake.
The Trimfizz formula includes Super CitriMax, an all-natural plant extract containing hydroxycitric acid. Similar to the citric acid in oranges and lemons, HCA has been shown to reduce appetite and inhibit fat production without stimulating the nervous system, changing the heart rate or blood pressure, nor interfering with sleep, the company claimed. The Super CitriMax in Trimfizz® contains 60 percent HCA, which is 20 percent higher than the usual quantity of HCA used for weight loss products.
Trimfizz is very low in sodium, is sugar-free, and also offers the benefits of fiber.
MacKay tapped as regulatory and scientific affairs VP for CRN
WASHINGTON The Council for Responsible Nutrition on Tuesday named Douglas (Duffy) MacKay to the post of vice president for regulatory and scientific affairs.
“We are extremely excited to welcome Dr. MacKay to our staff,” stated Steve Mister, CRN president and chief executive officer. “As a licensed naturopathic doctor, he adds an impressive combination of theoretical and practical expertise to our scientific team.”
Prior to joining CRN, MacKay served as vice president, clinical research, for Nordic Naturals, where during his four years with the company he was responsible for product formulation, coordinating clinical trial research, serving as technical/medical advisor, and managing the firm’s Adverse Event Reporting system, among other duties. MacKay also previously served as a senior technical advisor for Thorne Research and senior editor of the peer-reviewed clinical journal, Alternative Medicine Review. In addition, for seven years he was a co-owner and doctor in a complementary and alternative private practice, the Makai Naturopathic Center in New Hampshire.
MacKay will serve as CRN’s resident expert on botanicals, the association stated.
NSAIDs lower protien used in prostate cancer test
WASHINGTON Use of such nonsteroidal, anti-inflammatory drugs as ibuprofen or aspirin lowers the levels of a protein that doctors use to screen for prostate cancer, according to a report published in the medical journal Cancer, a Reuters report stated Monday.
However, it is unclear as to whether this means men taking an NSAID have a lower risk of developing potential prostate cancer, or if it simply means NSAIDs make it more difficult to identify prostate cancer in its early stages, the researchers concluded.